Futura Medical (FUM LN) First patient enrolled in Phase III trial of MED2002 | i-nexus Global (INX LN) Licence to execute | River and Mercantile Group (RIV LN) AuM +3% in Q1, positive flows in Equity Solutions | SDL (SDL LN) Capital Markets Event: clear strategy for profitable growth
31 Oct 2018
Morning Song
Futura Medical plc (FUM:LON), 35.5 | i-nexus Global plc (INX:LON), 3.2 | RWS Holdings plc (RWS:LON), 181
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Futura Medical plc (FUM:LON), 35.5 | i-nexus Global plc (INX:LON), 3.2 | RWS Holdings plc (RWS:LON), 181
- Published:
31 Oct 2018 -
Author:
N+1 Singer Team -
Pages:
11
Futura Medical (FUM LN) First patient enrolled in Phase III trial of MED2002 | i-nexus Global (INX LN) Licence to execute | River and Mercantile Group (RIV LN) AuM +3% in Q1, positive flows in Equity Solutions | SDL (SDL LN) Capital Markets Event: clear strategy for profitable growth